Global Bio-chem Technology Group Co. Ltd.

As of December 31, 2025, Global Bio-chem Technology Group Co. Ltd. carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at 4.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Global Bio-chem Technology Group Co. Ltd. has 1.68B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Global Bio-chem Technology Group Co. Ltd. maintains a current ratio of 0.49, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Global Bio-chem Technology Group Co. Ltd.'s stock has declined approximately 58.43% over the past 52 weeks. The 50-day moving average sits at 0.38, while the 200-day moving average is 0.54.

As of December 31, 2025, Global Bio-chem Technology Group Co. Ltd. holds 94.44M in cash and equivalents against 1.79B in total debt, resulting in a net debt position of 1.70B. Total book value stands at -2.25B, with working capital of -2.33B providing operational flexibility.

Global Bio-chem Technology Group Co. Ltd.'s most recent stock split took place on July 13, 2026 with a 10:1 split ratio.